168 related articles for article (PubMed ID: 15628717)
41. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
[TBL] [Abstract][Full Text] [Related]
42. Effect of GutsyGum(tm), A Novel Gum, on Subjective Ratings of Gastro Esophageal Reflux Following A Refluxogenic Meal.
Brown R; Sam CH; Green T; Wood S
J Diet Suppl; 2015 Jun; 12(2):138-45. PubMed ID: 25144853
[TBL] [Abstract][Full Text] [Related]
43. Esophageal dysfunction in esophagopharyngeal regurgitation.
Gerhardt DC; Castell DO; Winship DH; Shuck TJ
Gastroenterology; 1980 May; 78(5 Pt 1):893-7. PubMed ID: 7053042
[TBL] [Abstract][Full Text] [Related]
44. Effects of nitric oxide synthase blockade on esophageal peristalsis and the lower esophageal sphincter in the cat.
Xue S; Valdez D; Collman PI; Diamant NE
Can J Physiol Pharmacol; 1996 Nov; 74(11):1249-57. PubMed ID: 9028584
[TBL] [Abstract][Full Text] [Related]
45. Decreased esophageal peristaltic amplitude in response to prostaglandin E1 and prostacyclin in the baboon.
Sinar DR; Cordova CM; Fletcher JR; Castell DO
Dig Dis Sci; 1982 Dec; 27(12):1067-72. PubMed ID: 6756831
[TBL] [Abstract][Full Text] [Related]
46. Symptom hypersensitivity to acid infusion is associated with hypersensitivity of esophageal contractility.
Bhalla V; Liu J; Puckett JL; Mittal RK
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G65-71. PubMed ID: 14977636
[TBL] [Abstract][Full Text] [Related]
47. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease.
Storr M; Meining A; Allescher HD
Dig Dis; 2000; 18(2):93-102. PubMed ID: 11060472
[TBL] [Abstract][Full Text] [Related]
48. Gamma-aminobutyric acid receptor type B agonist baclofen inhibits acid-induced excitation of secondary peristalsis but not heartburn sensation.
Wong MW; Hung JS; Liu TT; Yi CH; Lei WY; Chen CL
J Gastroenterol Hepatol; 2019 Feb; 34(2):370-375. PubMed ID: 30069912
[TBL] [Abstract][Full Text] [Related]
49. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
[TBL] [Abstract][Full Text] [Related]
50. Esophageal solid bolus transit: studies using concurrent videofluoroscopy and manometry.
Pouderoux P; Shi G; Tatum RP; Kahrilas PJ
Am J Gastroenterol; 1999 Jun; 94(6):1457-63. PubMed ID: 10364007
[TBL] [Abstract][Full Text] [Related]
51. Esophageal function and Sjögren's syndrome.
Volter F; Fain O; Mathieu E; Thomas M
Dig Dis Sci; 2004 Feb; 49(2):248-53. PubMed ID: 15104365
[TBL] [Abstract][Full Text] [Related]
52. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.
Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J
Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138
[TBL] [Abstract][Full Text] [Related]
53. [Association between acid reflux and esophageal dysmotility in patients with gastroesophageal reflux disease].
Yi ZH; Feng L; Wen MY; Liu JR; Yang L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):480-3. PubMed ID: 24941823
[TBL] [Abstract][Full Text] [Related]
54. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms.
Fouad YM; Katz PO; Hatlebakk JG; Castell DO
Am J Gastroenterol; 1999 Jun; 94(6):1464-7. PubMed ID: 10364008
[TBL] [Abstract][Full Text] [Related]
55. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility.
Agrawal A; Hila A; Tutuian R; Mainie I; Castell DO
J Clin Gastroenterol; 2007 Apr; 41(4):366-70. PubMed ID: 17413603
[TBL] [Abstract][Full Text] [Related]
56. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.
Singh P; Taylor RH; Colin-Jones DG
Am J Gastroenterol; 1994 Mar; 89(3):349-56. PubMed ID: 8122643
[TBL] [Abstract][Full Text] [Related]
57. Esophageal solid bolus transit: studies using combined multichannel intraluminal impedance and manometry in healthy volunteers.
Chen CL; Yi CH; Chou AS; Liu TT
Dis Esophagus; 2013 Jan; 26(1):91-6. PubMed ID: 22394249
[TBL] [Abstract][Full Text] [Related]
58. Effects of esophageal acid infusion vs mosapride on distension-induced secondary peristalsis in humans.
Lei WY; Hung JS; Yi CH; Liu TT; Wong MW; Chen CL
Kaohsiung J Med Sci; 2019 May; 35(5):310-314. PubMed ID: 30897296
[TBL] [Abstract][Full Text] [Related]
59. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
[TBL] [Abstract][Full Text] [Related]
60. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults.
Rhee PL; Hyun JG; Lee JH; Kim YH; Son HJ; Kim JJ; Paik SW; Rhee JC; Choi KW
Am J Gastroenterol; 2001 Dec; 96(12):3251-7. PubMed ID: 11774933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
